Year : 2024
Deciphering the molecular mechanism of REST regulation through DEGs and TFs in Alzheimer’s disease
Cite this Research Publication : Nassar A, Nampoothiri M, Gurram PC, Satarker S, Upadhya D, Gayathri S. Deciphering the molecular mechanism of REST regulation through DEGs and TFs in Alzheimer’s disease. Journal of Applied Pharmaceutical Sciences. 2024;14(02):083–092. doi: 10.7324/JAPS.2023.152245. (JOURNAL OF APPLIED PHARMACEUTICAL SCIENCES, Q2)
Publisher : Journal of Applied Pharmaceutical Sciences
Year : 2023
Virtual structure-based docking and molecular dynamics of FDA-approved drugs for the identification of potential IKKB inhibitors possessing dopaminergic activity in Alzheimer’s disease
Cite this Research Publication : Gurram PC, Satarker S, Nassar A. Virtual structure-based docking and molecular dynamics of FDA-approved drugs for the identification of potential IKKB inhibitors possessing dopaminergic activity in Alzheimer’s disease. Chemical Papers. 2023;77:1971–1988. doi: 10.1007/s11696-022-02598-y. (CHEMICAL PAPERS, Q1, 2.22)
Publisher : Chemical Papers
Year : 2023
Evaluating the Role of N-Acetyl-L-Tryptophan in the Aβ 1-42-Induced Neuroinflammation and Cognitive Decline in Alzheimer’s Disease
Cite this Research Publication : Satarker S, Gurram PC, Nassar A, Manandhar S, Vibhavari R, Yarlagadda DL, Mudgal J, Lewis S, Arora D, Nampoothiri M. Evaluating the Role of N-Acetyl-L-Tryptophan in the Aβ 1-42-Induced Neuroinflammation and Cognitive Decline in Alzheimer's Disease. Molecular Neurobiology. 2023 Dec 13. doi: 10.1007/s12035-023-03844-4. Epub ahead of print. PMID: 38091207. (MOLECULAR NEUROBIOLOGY, Q1, 5.66)
Publisher : Molecular Neurobiology
Year : 2023
Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson’s disease and advanced therapeutic strategies
Cite this Research Publication : Nassar A, Kodi T, Satarker S, Gurram PC, Fayaz SM, Nampoothiri M. Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson's disease and advanced therapeutic strategies. Gene. 2024 Jan 20;892:147898. doi: 10.1016/j.gene.2023.147898. Epub 2023 Oct 11. PMID: 37832803. (GENES, IF 3.991)
Publisher : Gene
Year : 2023
Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies
Cite this Research Publication : Nassar A, Satarker S, Gurram PC, Upadhya D, Fayaz SM, Nampoothiri M. Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies. Molecular Neurobiology. 2023 Oct;60(10):5557-5577. doi: 10.1007/s12035-023-03437-1. Epub 2023 Jun 16. PMID: 37326903; PMCID: PMC10471693. (MOLECULAR NEUROBIOLOGY, Q1, 5.66)
Publisher : Molecular Neurobiology
Year : 2022
Astrocytic MicroRNAs and Transcription Factors in Alzheimer’s Disease and Therapeutic Interventions
Cite this Research Publication : Nassar A, Kodi T, Satarker S, ChowdariGurram P, Upadhya D, Fayaz SM, Mudgal J, Nampoothiri M. Astrocytic MicroRNAs and Transcription Factors in Alzheimer's Disease and Therapeutic Interventions. Cells. 2022 Dec 17;11(24):4111. doi: 10.3390/cells11244111. PMID: 36552875; PMCID: PMC9776935. (CELLS, Q1, 7.66)
Publisher : Cells